Artivion, Inc. (AORT)
NYSE: AORT · IEX Real-Time Price · USD
19.80
-0.80 (-3.88%)
Apr 30, 2024, 3:14 PM EDT - Market open

Artivion Revenue

In the year 2023, Artivion had annual revenue of $354.00M with 12.82% growth. Revenue in the quarter ending December 31, 2023 was $93.67M with 17.98% year-over-year growth.

Revenue (ttm)
$354.00M
Revenue Growth
+12.82%
P/S Ratio
2.41
Revenue / Employee
$236,003
Employees
1,500
Market Cap
826.27M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023354.00M40.22M12.82%
Dec 31, 2022313.79M14.95M5.00%
Dec 31, 2021298.84M45.61M18.01%
Dec 31, 2020253.23M-23.00M-8.32%
Dec 31, 2019276.22M13.38M5.09%
Dec 31, 2018262.84M73.14M38.55%
Dec 31, 2017189.70M9.32M5.17%
Dec 31, 2016180.38M34.48M23.63%
Dec 31, 2015145.90M1.26M0.87%
Dec 31, 2014144.64M3.88M2.75%
Dec 31, 2013140.76M9.05M6.87%
Dec 31, 2012131.72M12.09M10.11%
Dec 31, 2011119.63M2.98M2.56%
Dec 31, 2010116.65M4.96M4.44%
Dec 31, 2009111.69M6.63M6.31%
Dec 31, 2008105.06M10.30M10.87%
Dec 31, 200794.76M13.45M16.54%
Dec 31, 200681.31M12.03M17.36%
Dec 31, 200569.28M6.90M11.06%
Dec 31, 200462.38M2.85M4.79%
Dec 31, 200359.53M-18.26M-23.48%
Dec 31, 200277.80M-9.88M-11.26%
Dec 31, 200187.67M10.58M13.72%
Dec 31, 200077.10M10.37M15.55%
Dec 31, 199966.72M6.03M9.94%
Dec 31, 199860.69M10.12M20.01%
Dec 31, 199750.57M13.71M37.18%
Dec 31, 199636.87M7.64M26.14%
Dec 31, 199529.23M5.42M22.75%
Dec 31, 199423.81M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OPKO Health 863.50M
Avanos Medical 673.30M
BioCryst Pharmaceuticals 331.41M
MiMedx Group 321.48M
Simulations Plus 64.67M
MacroGenics 58.75M
EyePoint Pharmaceuticals 46.02M
Relay Therapeutics 25.55M
Revenue Rankings